Immunization with a recombinant bacillus calmette-guérin strain confers protective Th1 immunity against the human metapneumovirus

Journal of Immunology

Volumn 192, Issue 1, 2014, Pages 214-223

  Palavecino, Christian E ^a   Céspedes, Pablo F ^a   Gómez, Roberto S ^a,b   Kalergis, Alexis M ^a,b,c   Bueno, Susan M ^a,b  

^a Pontificia Universidad Católica de Chile   (Chile)

^b INSERM   (France)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 2; PROTEIN M2; VIRUS PHOSPHOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AND IMMUNOGLOBULIN PRODUCTION; ARTICLE; BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL TRANSFER; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE; HISTOPATHOLOGY; HUMAN METAPNEUMOVIRUS; HUMAN METAPNEUMOVIRUS INFECTION; IMMUNIZATION; IMMUNOLOGICAL MEMORY; INFECTION PREVENTION; LUNG ALVEOLUS CELL; M2 1 GENE; MOUSE; MYCOBACTERIUM BOVIS BCG; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REINFECTION; RESPIRATORY TRACT INFLAMMATION; T LYMPHOCYTE ACTIVATION; TH1 CELL; VIRUS IMMUNITY; VIRUS REPLICATION; WEIGHT REDUCTION;

EID: 84891133216     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300118     Document Type: Article

References (36)

1. van den Hoogen, B. G., J. C. de Jong, J. Groen, T. Kuiken, R. de Groot, R. A. Fouchier, and A. D. Osterhaus. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7: 719-724.
2. Feuillet, F., B. Lina, M. Rosa-Calatrava, and G. Boivin. 2012. Ten years of human metapneumovirus research. J. Clin. Virol. 53: 97-105.
3. Gaunt, E. R., R. R. Jansen, Y. Poovorawan, K. E. Templeton, G. L. Toms, and P. Simmonds. 2011. Molecular epidemiology and evolution of human respiratory syncytial virus and human metapneumovirus. PLoS ONE 6: e17427.
4. Boivin, G., G. De Serres, S. Côté, R. Gilca, Y. Abed, L. Rochette, M. G. Bergeron, and P. Déry. 2003. Human metapneumovirus infections in hospitalized children. Emerg. Infect. Dis. 9: 634-640.
5. Boivin, G., G. De Serres, M. E. Hamelin, S. Côté, M. Argouin, G. Tremblay, R. Maranda-Aubut, C. Sauvageau, M. Ouakki, N. Boulianne, and C. Couture. 2007. An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin. Infect. Dis. 44: 1152-1158.
6. de Swart, R. L., B. G. van den Hoogen, T. Kuiken, S. Herfst, G. van Amerongen, S. Yüksel, L. Sprong, and A. D. Osterhaus. 2007. Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection. Vaccine 25: 8518-8528.
7. Yim, K. C., R. P. Cragin, M. S. Boukhvalova, J. C. Blanco, M. E. Hamlin, G. Boivin, D. D. Porter, and G. A. Prince. 2007. Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged. Vaccine 25: 5034-5040.
8. Cseke, G., D. W. Wright, S. J. Tollefson, J. E. Johnson, J. E. Crowe, Jr., and J. V. Williams. 2007. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J. Virol. 81: 698-707.
9. Herfst, S., E. J. Schrauwen, M. de Graaf, G. van Amerongen, B. G. van den Hoogen, R. L. de Swart, A. D. Osterhaus, and R. A. Fouchier. 2008. Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques. Vaccine 26: 4224-4230.
10. Alvarez, R., K. S. Harrod, W. J. Shieh, S. Zaki, and R. A. Tripp. 2004. Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies. J. Virol. 78: 14003-14011.
11. Hamelin, M. E., C. Couture, M. Sackett, P. Kiener, J. Suzich, N. Ulbrandt, and G. Boivin. 2008. The prophylactic administration of a monoclonal antibody against human metapneumovirus attenuates viral disease and airways hyperresponsiveness in mice. Antivir. Ther. (Lond.) 13: 39-46.
12. Ulbrandt, N. D., H. Ji, N. K. Patel, J. M. Riggs, Y. A. Brewah, S. Ready, N. E. Donacki, K. Folliot, A. S. Barnes, K. Senthil, et al. 2006. Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo. J. Virol. 80: 7799-7806.
13. Bastien, N., S. Normand, T. Taylor, D. Ward, T. C. Peret, G. Boivin, L. J. Anderson, and Y. Li. 2003. Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains. Virus Res. 93: 51-62.
14. Goutagny, N., Z. Jiang, J. Tian, P. Parroche, J. Schickli, B. G. Monks, N. Ulbrandt, H. Ji, P. A. Kiener, A. J. Coyle, and K. A. Fitzgerald. 2010. Cell type-specific recognition of human metapneumoviruses (HMPVs) by retinoic acid-inducible gene I (RIG-I) and TLR7 and viral interference of RIG-I ligand recognition by HMPV-B1 phosphoprotein. J. Immunol. 184: 1168-1179.
15. Herd, K. A., M. Nelson, S. Mahalingam, and R. W. Tindle. 2010. Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus. J. Gen. Virol. 91: 1302-1310.
16. Melendi, G. A., F. Zavala, U. J. Buchholz, G. Boivin, P. L. Collins, S. R. Kleeberger, and F. P. Polack. 2007. Mapping and characterization of the primary and anamnestic H-2d-restricted cytotoxic T-lymphocyte response in mice against human metapneumovirus. J. Virol. 81: 11461-11467.
17. Biacchesi, S., Q. N. Pham, M. H. Skiadopoulos, B. R. Murphy, P. L. Collins, and U. J. Buchholz. 2005. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J. Virol. 79: 12608-12613.
18. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19: 93-129.
19. Hanekom, W. A. 2005. The immune response to BCG vaccination of newborns. Ann. N. Y. Acad. Sci. 1062: 69-78.
20. Marchant, A., T. Goetghebuer, M. O. Ota, I. Wolfe, S. J. Ceesay, D. De Groote, T. Corrah, S. Bennett, J. Wheeler, K. Huygen, et al. 1999. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J. Immunol. 163: 2249-2255.
21. Bueno, S. M., P. A. González, K. M. Cautivo, J. E. Mora, E. D. Leiva, H. E. Tobar, G. J. Fennelly, E. A. Eugenin, W. R. Jacobs, Jr., C. A. Riedel, and A. M. Kalergis. 2008. Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc. Natl. Acad. Sci. USA 105: 20822-20827.
22. Cautivo, K. M., S. M. Bueno, C. M. Cortes, A. Wozniak, C. A. Riedel, and A. M. Kalergis. 2010. Efficient lung recruitment of respiratory syncytial virusspecific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection. J. Immunol. 185: 7633-7645.
23. Reina, J., F. Ferres, E. Alcoceba, A. Mena, E. R. de Gopegui, and J. Figuerola. 2007. Comparison of different cell lines and incubation times in the isolation by the shell vial culture of human metapneumovirus from pediatric respiratory samples. J. Clin. Virol. 40: 46-49.
24. Tollefson, S. J., R. G. Cox, and J. V. Williams. 2010. Studies of culture conditions and environmental stability of human metapneumovirus. Virus Res. 151: 54-59.
25. Céspedes, P. F., P. A. Gonzalez, and A. M. Kalergis. 2013. Human metapneumovirus keeps dendritic cells from priming antigen-specific naive T cells. Immunology 139: 366-376.
26. Fennelly, G. J., J. L. Flynn, V. Ter Meulen, U. G. Liebert, and B. R. Bloom. 1995. Recombinant bacille Calmette-Guérin priming against measles. J. Infect. Dis. 172: 698-705.
27. Ain, R., J. S. Tash, and M. J. Soares. 2002. A simple method for the in situ detection of eosinophils. J. Immunol. Methods 260: 273-278.
28. Baer, G., U. B. Schaad, and U. Heininger. 2008. Clinical findings and unusual epidemiologic characteristics of human metapneumovirus infections in children in the region of Basel, Switzerland. Eur. J. Pediatr. 167: 63-69.
29. Ito, T., A. Hasegawa, H. Hosokawa, M. Yamashita, S. Motohashi, T. Naka, Y. Okamoto, Y. Fujita, Y. Ishii, M. Taniguchi, et al. 2008. Human Th1 differentiation induced by lipoarabinomannan/lipomannan from Mycobacterium bovis BCG Tokyo-172. Int. Immunol. 20: 849-860.
30. Christy, A. J., K. Dharman, G. Dhandapaani, K. Palaniyandi, U. D. Gupta, P. Gupta, S. Ignacimuthu, and S. Narayanan. 2012. Epitope based recombinant BCG vaccine elicits specific Th1 polarized immune responses in BALB/c mice. Vaccine 30: 1364-1370.
31. Baumann, S., A. Nasser Eddine, and S. H. Kaufmann. 2006. Progress in tuberculosis vaccine development. Curr. Opin. Immunol. 18: 438-448.
32. Hwang, S. A., K. Wilk, M. L. Kruzel, and J. K. Actor. 2009. A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice. Vaccine 27: 3026-3034.
33. Nascimento, I. P., W. O. Dias, W. Quintilio, A. P. Christ, J. F. Moraes, M. D. Vancetto, G. Ribeiro-Dos-Santos, I. Raw, and L. C. Leite. 2008. Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge. Microbes Infect. 10: 198-202.
34. Chapman, R., G. Chege, E. Shephard, H. Stutz, and A. L. Williamson. 2010. Recombinant Mycobacterium bovis BCG as an HIV vaccine vector. Curr. HIV Res. 8: 282-298.
35. Teo, W. H., A. A. Nurul, and M. N. Norazmi. 2012. Immunogenicity of recombinant BCG-based vaccine expressing the 22 kDa of serine repeat antigen (SE22) of Plasmodium falciparum. Trop. Biomed. 29: 239-253.
36. Zhang, Z. J. 1990. [Surveillance and control of ARI among urban nurseries in Beijing]. Zhonghua Liu Xing Bing Xue Za Zhi 11: 145-149.